Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 990, pseudogene (RNU6-990P) is classified as a **pseudogene** related to the U6 small nuclear RNA (snRNA) family[2][5]. U6 snRNA is an essential component of the spliceosome, the cellular machine responsible for removing introns from pre-mRNA during post-transcriptional RNA processing[1][3]. However, pseudogenes such as RNU6-990P are sequences in the genome that closely resemble functional genes (in this case, U6 snRNA) but are generally non-functional: they do not produce a functional RNA or protein product and lack established biological functions or disease links[2][5]. While some small RNA pseudogenes can occasionally be transcribed or used as molecular fossils tracing genome evolution, RNU6-990P itself is not recognized as a biological target, biomarker, or therapeutic receptor, nor is it known to interact with drugs or to have roles in disease. **Key justifications:** - **is_target: false** because pseudogenes do not encode functional receptors, enzymes, or other molecules typically targeted by therapeutics[2][5]. - **is_incorrect: true** because RNU6-990P is not a true therapeutic target or functional molecule; it's a pseudogene[2][5]. - **molecular_classifications:** "Other", "Pseudogene", "Small nuclear RNA pseudogene" are appropriate, as it does not fit receptor, enzyme, transporter, or other protein classifications[2][5]. If you require information about the functional U6 snRNA molecule (the actual spliceosomal component, not the pseudogene), a new query should be made for "U6 small nuclear RNA" or "RNU6-1".
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 990, pseudogene (RNU6-990P).